Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05545280 · ClinicalTrials.gov registry record · Phase 4
Postoperative Urinary Retention in Patients After Noncardiac Surgery and Reversal of Neuromuscular Block
A Phase 4 study, sponsored by The Cleveland Clinic.
- Completed
- Registry status
- Phase 4
- Development phase
- 50
- Enrollment target
NCT05545280 is a Phase 4 study that has completed, run by The Cleveland Clinic. The registered enrollment target is 50 participants.
The verdict
NCT05545280, a Phase 4 study, has completed, sponsored by The Cleveland Clinic.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 50 participants
- Enrollment target
Study Summary
The investigators propose a randomized trial comparing sugammadex and neostigmine for the reversal of neuromuscular blocks induced by rocuronium or vecuronium in adults having general anesthesia with muscular block for noncardiac surgery.
Interventions
- DRUG Sugammadex
- DRUG Neostigmine with glycopyrrolate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2023-12-01 |
| Est. Completion | 2024-08-07 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05545280
The ClinicalTrials.gov registry entry for NCT05545280 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The Cleveland Clinic, which has 688 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Sugammadex is the first listed.
NCT05545280 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05545280 about?
NCT05545280 is a clinical study titled "Postoperative Urinary Retention in Patients After Noncardiac Surgery and Reversal of Neuromuscular Block". The investigators propose a randomized trial comparing sugammadex and neostigmine for the reversal of neuromuscular blocks induced by rocuronium or vecuronium in adults having general anesthesia with muscular block for noncardiac surgery.
What is the current status of trial NCT05545280?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 50 participants. The study started on 2023-12-01. Estimated completion is 2024-08-07.
What interventions are being tested in trial NCT05545280?
The interventions under investigation include: Sugammadex (DRUG), Neostigmine with glycopyrrolate (DRUG).
Who is sponsoring clinical trial NCT05545280?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.